The UCL Ventura Flow Generator is a non-invasive ventilation (NIV) system specifically developed to aid COVID-19 patients with breathing difficulties. It is an improved design of the continuous positive airway pressure (CPAP) system that optimizes oxygen consumption.
A non-invasive ventilation system specifically developed to aid COVID-19 patients with breathing difficulties.
Uses a modified continuous positive airway pressure (CPAP) technology to open lung bases and deliver.
Oxygenation with little or no sedation and without the need for invasive ventilation.
Designed to optimized oxygen consumption and maximize saving in operation cost.
Configured to reduce the spread if aerosols, keeping healthcare practitioners safe from infection.
Although the UCL Ventura is not a direct replacement for invasive mechanical ventilation (IMV), this NIV system can serve as supportive therapy for COVID-19 patients experiencing mild to severe symptoms and may be used to prevent patients from progressing to the point of needing IMV, or as a bridging therapy for cases where IMV is unavailable. This may help improve patient outcomes while reducing the strain on hospital resources.
UCL Ventura Flow Generator Brochure
Continuous Positive Airway Pressure device for COVID-19.
UK NHS REFERENCES
IMI is able to tap different markets and advanced systems globally, providing a complete array of product design, building and manufacturing services while remaining competitive on a global basis."
Arthur R. Tan, Vice Chairman and CEO
we help you?